Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level

The system integrated by the receptor activator of nuclear factor kappa B (RANK) and its ligand, RANKL, modulates the role of hormones in the genesis and progression of breast tumors. We investigated whether the expression of RANK was related with clinicopathological features of primary endometrial...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Raúl, Castro, Ana, Martínez, Jessica, Rodríguez-García, Víctor, Burgués, Octavio, Tarín, Juan J., Cano, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073139/
https://www.ncbi.nlm.nih.gov/pubmed/29932437
http://dx.doi.org/10.3390/ijms19071848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073139/
https://www.ncbi.nlm.nih.gov/pubmed/29932437
http://dx.doi.org/10.3390/ijms19071848

Ejemplares similares